Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes

por Gibson, EJ, Begum, N, Koblbauer, I, Dranitsaris, G, Liew, D, McEwan, P, Tahami Monfared, AA, Yuan, Y, Juarez-Garcia, A, Tyas, D, Lees, M
Publicado 2018

P963: EVOLUTION OF TREATMENT PATTERNS AND OVERALL SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING A SECOND LINE OF THERAPY BETWEEN 2012 AND 2020: ANALYSIS...

por Kuter, D., Goldschmidt, H., Cella, D., Petrucci, M. T., Moreau, P., Durie, B., Juarez-Garcia, A., Trong, L., Gu, J., Hernandez Rivera, G., Dhanasiri, S., Marshall, T., Wang, J., Lacoin, L., Ramasamy, K., Vij, R.
Publicado 2022